| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/19/2007 | US7232909 Pyridine derivatives |
| 06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 06/19/2007 | US7232904 Crystal of arylethenesulfonamide derivative and preparation process thereof |
| 06/19/2007 | US7232827 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives |
| 06/19/2007 | US7232814 Heterocyclic carboxy amines such as 9-nitro-7,12-dihydroindolo (3,2-d)(1)-benzazepin-6(5H)-one, used as inhibitors of glycogen synthase kinase-3 beta or cyclin dependent kinases |
| 06/19/2007 | US7232802 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 06/19/2007 | CA2158745C Inhibitor of vascular endothelial cell growth factor |
| 06/14/2007 | WO2007067957A1 Structural carotenoid analogs or derivatives for the modulation of systemic and/or target organ redox status |
| 06/14/2007 | WO2007067817A1 Abca1 elevating compounds |
| 06/14/2007 | WO2007067570A1 Methods and compositions for the treatment of disease |
| 06/14/2007 | WO2007065539A1 Extracts of gynostemma and compositions for reducing blood lipid levels |
| 06/14/2007 | WO2007065303A1 Transdermal patch containing isosorbide dinitrate and bisoprolol |
| 06/14/2007 | WO2007065226A1 Vip fragments and methods of use |
| 06/14/2007 | WO2007050721A3 Heterocyclic aspartyl protease inhibitors |
| 06/14/2007 | WO2007048352B1 Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries |
| 06/14/2007 | WO2007047401A3 A1 adenosine receptor agonists |
| 06/14/2007 | WO2007045639A8 Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
| 06/14/2007 | WO2007004685A3 Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070135502 Heterocyclic compounds and methods of use |
| 06/14/2007 | US20070135488 Amlodipine nicotinate and process for the preparation thereof |
| 06/14/2007 | US20070135484 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 06/14/2007 | US20070135458 6-Substituted pyrido-pyrimidines |
| 06/14/2007 | US20070135433 Imidazole derivatives as raf kinase inhibitors |
| 06/14/2007 | US20070135411 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 06/14/2007 | US20070135409 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 06/14/2007 | US20070135402 Azetidine ring compounds and drugs comprising the same |
| 06/14/2007 | US20070135365 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiovascular disease caused thereby |
| 06/14/2007 | US20070135348 Methods and compositions for the treatment of peripheral artery disease |
| 06/14/2007 | US20070135344 Novel growth factor and a genetic sequence encoding same |
| 06/14/2007 | US20070134314 Therapeutic inhibitor of vascular smooth muscle cells |
| 06/14/2007 | US20070134260 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 06/14/2007 | US20070134250 Composition Comprising and Method of Using Angiopoietin-Like Protein 3 ANGPTL3 |
| 06/14/2007 | DE102005058345A1 Verwendung eines oral einzunehmenden Antibiotikums Use of orally administered antibiotic |
| 06/14/2007 | CA2632581A1 Vip fragments and methods of use |
| 06/14/2007 | CA2631740A1 Methods and compositions for the treatment of disease |
| 06/14/2007 | CA2630233A1 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors |
| 06/13/2007 | EP1795193A1 Suppressant for cerebral infarction attributed to long-time ischemia |
| 06/13/2007 | EP1795192A2 1-Substituted imidazole derivatives as nos inhibitors |
| 06/13/2007 | EP1794162A1 Purine derivatives as a3 and a1 adenosine receptor agonists |
| 06/13/2007 | EP1794150A1 Benzimidazole derivatives and their use as cannabinoid receptor ligands I |
| 06/13/2007 | EP1794128A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, their use as a medicament, and a medicament containing them |
| 06/13/2007 | EP1793832A2 Geranylgeranyl pyrophosphate synthase inhibitors |
| 06/13/2007 | EP1793818A2 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
| 06/13/2007 | EP1793814A2 Thyroid hormone analogs for promoting angiogenesis |
| 06/13/2007 | EP1793690A1 Acorus gramineus soland extract for preventing and treating ischemic heart disease and pharmaceutical composition and health food containing the same |
| 06/13/2007 | EP1519908B1 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/13/2007 | EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 06/13/2007 | EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 06/13/2007 | EP1416931B1 Inhibitors of polyq-aggregation |
| 06/13/2007 | EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2007 | EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 06/13/2007 | EP1330425B1 C-nitroso compounds and use thereof |
| 06/13/2007 | EP1302542B1 Novel physiologically active peptide and use thereof |
| 06/13/2007 | EP1299358B1 Pyridoxine and pyridoxal analogues as cardiovascular therapeutics |
| 06/13/2007 | EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 06/13/2007 | EP1220679B1 Cell-based gene therapy for the pulmonary system |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1105145B1 Reducing serum homocysteine concentration by the use of allium and vitamins |
| 06/13/2007 | EP1100895B1 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 06/13/2007 | EP1027429B1 Jnk3 modulators and methods of use |
| 06/13/2007 | EP0889972B1 Use of the determination of polymorphims in the promoter region of the TGF-beta 1 gene in diagnosis |
| 06/13/2007 | EP0792278B1 Tumor necrosis factor-gamma |
| 06/13/2007 | CN1980923A Polycyclic pyridines as potassium ion channel modulators |
| 06/13/2007 | CN1980910A Benzopyran compound for treating arrhythmia |
| 06/13/2007 | CN1980901A Biaryl derivatives |
| 06/13/2007 | CN1980673A A method for the prevention of thromboembolic disorders |
| 06/13/2007 | CN1978452A New process for preparing isoquercitrin |
| 06/13/2007 | CN1977975A Inclusion puerarin/cyclodextrin composition and its preparing method |
| 06/13/2007 | CN1977954A Chinese medicine tea bag |
| 06/13/2007 | CN1977952A Chinese medicine preparation for treating stroke |
| 06/13/2007 | CN1977945A Method for extracting active ingredient from red ginseng and lilyturf root |
| 06/13/2007 | CN1977944A Red ginseng and lilyturf root soft capsule and its preparing method |
| 06/13/2007 | CN1977919A Chinese medicine preparation for treating coronary heart disease angina pectoris and its preparing method |
| 06/13/2007 | CN1977909A Hawthorn leaf total flavone sustained-release tablet and its preparing method |
| 06/13/2007 | CN1977908A Chinese medicine composition for treating cardio-cerebrovascular disease |
| 06/13/2007 | CN1977902A Injection total saponins of paeonia powder without additive material |
| 06/13/2007 | CN1977898A Chinese medicine for treating cardio-cerebrovascular disease |
| 06/13/2007 | CN1977892A Method for regulating baicalin and baicalein ratio in scutellariae root extract |
| 06/13/2007 | CN1977891A Chinese medicine particle agent for treating coronary heart disease and its preparing method |
| 06/13/2007 | CN1977890A Chinese medicine composition and its use |
| 06/13/2007 | CN1977881A Injection medicine for treating cardio-cerebrovascular disease, and its preparing method |
| 06/13/2007 | CN1977878A Chinese medicine composition and its use |
| 06/13/2007 | CN1977877A Medicinal composition containing rhodiola and safflower yellow, and its use |
| 06/13/2007 | CN1977876A Medicinal composition containing rhodiola and ginkgo leaf, and its use |
| 06/13/2007 | CN1977874A Chinese medicine tablet of total coumarins extract from peucedanum praeruptorm, and its preparing method and use |
| 06/13/2007 | CN1977871A Chinese medicine preparation of total coumarins extract from peu cedanum praeruptorum dunn, and its preparing method and use |
| 06/13/2007 | CN1977870A Total coumarins extract from peucedanum praeruptorum dunn, and its preparing method and use |
| 06/13/2007 | CN1977839A Medicinal composition for treating cerebrovascular disease and its preparing method |
| 06/13/2007 | CN1977838A Pharmaceutical use of senkyunolide A, and medicinal composition containing it and its prepairng method |
| 06/13/2007 | CN1977837A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977836A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977830A Preparation of carvedilo dispersible tablet |
| 06/13/2007 | CN1977827A Ibutilide fumarate lyophilized powderinjection preparation and its preparing method |
| 06/13/2007 | CN1321133C Human blood high density lipoprotein and its preparation method and use |
| 06/13/2007 | CN1321129C Inhibitors of caspases |
| 06/13/2007 | CN1321112C Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker |
| 06/13/2007 | CN1321106C New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it |
| 06/13/2007 | CN1320929C Agents for gene therapeutic for cerebrovascular disorders |